1,098
Views
20
CrossRef citations to date
0
Altmetric
Review

Immunogenicity, safety and tolerability of intradermal influenza vaccines

&
Pages 565-570 | Received 03 Mar 2017, Accepted 05 May 2017, Published online: 06 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Alberto Migliore, Gianfranco Gigliucci, Raffaele Di Marzo, Domenico Russo & Massimo Mammucari. (2021) Intradermal Vaccination: A Potential Tool in the Battle Against the COVID-19 Pandemic?. Risk Management and Healthcare Policy 14, pages 2079-2087.
Read now
Ruiqi Zhang & Ivan Fan-Ngai Hung. (2021) Approaches in broadening the neutralizing antibody response of the influenza vaccine. Expert Review of Vaccines 20:12, pages 1539-1547.
Read now
Susanna Esposito. (2018) 100 years since the 1918 influenza pandemic. Human Vaccines & Immunotherapeutics 14:3, pages 504-507.
Read now

Articles from other publishers (17)

Camilla Edwards, Shrey. A. Shah, Thomas Gebhardt & Christopher M. Jewell. (2023) Exploiting Unique Features of Microneedles to Modulate Immunity. Advanced Materials.
Crossref
Nimisha Rikhi, Clara J. Sei, Mangala Rao, Richard F. Schuman, Kellie A. Kroscher, Gary R. Matyas, Kevin Muema, Camille Lange, Aba Assiaw-Dufu, Elizabeth Hussin, Ousman Jobe, Carl R. Alving & Gerald W. Fischer. (2023) Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses. Vaccines 11:9, pages 1468.
Crossref
Tomokazu Amano, Hong Yu, Misa Amano, Erica Leyder, Maria Badiola, Priyanka Ray, Jiyoung Kim, Akihiro C. Ko, Achouak Achour, Nan-ping Weng, Efrat Kochba, Yotam Levin & Minoru S.H. Ko. (2023) Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity. iScience 26:4, pages 106335.
Crossref
Frank LichtenbergerFrank Lichtenberger. 2023. Allergic to Life. Allergic to Life 19 35 .
Pierre A. Morgon. 2022. Principles of Biomedical Sciences and Industry. Principles of Biomedical Sciences and Industry 377 396 .
Birgit Weinberger. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System 119 164 .
Ivan Fan-Ngai Hung, Desmond Yat-Hin Yap, Terence Pok-Siu Yip, Ricky Ruiqi Zhang, Kelvin Kai-Wang To, Kwok-Hung Chan, Sydney Chi-Wai Tang, Sing-Leung Lui, Yotam Levin, Efrat Kochba, Johnson Yiu-Nam Lau, Man-Fung Yuen, Tak-Mao Chan & Kwok-Yung Yuen. (2021) A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis. Clinical Infectious Diseases 73:2, pages e304-e311.
Crossref
Oluwaseun Egunsola, Fiona Clement, John Taplin, Liza Mastikhina, Joyce W. Li, Diane L. Lorenzetti, Laura E. Dowsett & Tom Noseworthy. (2021) Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines. JAMA Network Open 4:2, pages e2035693.
Crossref
Evgeniia Korotchenko, Viktoria Schießl, Sandra Scheiblhofer, Mario Schubert, Elfriede Dall, Isabella A. Joubert, Helen Strandt, Theresa Neuper, Muamera Sarajlic, Renate Bauer, Mark Geppert, David Joedicke, Sabrina Wildner, Susanne Schaller, Stephan Winkler, Gabriele Gadermaier, Jutta Horejs‐Hoeck & Richard Weiss. (2020) Laser‐facilitated epicutaneous immunotherapy with hypoallergenic beta‐glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma. Allergy 76:1, pages 210-222.
Crossref
Diahann TSL Jansen, Yingying Dou, Janet W de Wilde, Andrea M Woltman & Sonja I Buschow. (2021) Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures. Clinical & Translational Immunology 10:1.
Crossref
Mona O. Mohsen, Gilles Augusto & Martin F. Bachmann. (2020) The 3Ds in virus‐like particle based‐vaccines: “ Design, Delivery and Dynamics ” . Immunological Reviews 296:1, pages 155-168.
Crossref
Angelika Wagner & Birgit Weinberger. (2020) Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Frontiers in Immunology 11.
Crossref
José Antonio Navarro Alonso. (2020) La gripe: 76 años de vacuna antigripal… ¡y de la hemaglutinina!. Revista Madrileña de Salud Pública 3:11, pages 1-8.
Crossref
Chinyang Chang, Jiao Sun, Hiroki Hayashi, Ayano Suzuki, Yuko Sakaguchi, Hiroshi Miyazaki, Tomoyuki Nishikawa, Hironori Nakagami, Kunihiko Yamashita & Yasufumi Kaneda. (2019) Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector. AAPS PharmSciTech 21:1.
Crossref
Milton Maciel, Mark Smith, Steven T. Poole, Renee M. Laird, Julianne E. Rollenhagen, Robert W. Kaminski, Heather Wenzel, A. Louis Bourgeois & Stephen J. Savarino. (2019) Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice. PLOS ONE 14:11, pages e0224073.
Crossref
Brian K. Meyer, Mark A.F. Kendall, Donna M. Williams, Andrew J. Bett, Sheri Dubey, Renee C. Gentzel, Danilo Casimiro, Angus Forster, Holly Corbett, Michael Crichton, S. Ben Baker, Robert K. Evans & Akhilesh Bhambhani. (2019) Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment. Vaccine: X 2, pages 100030.
Crossref
Bert Schepens, Pieter Jan Vos, Xavier Saelens & Koen van der Maaden. (2019) Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses. European Journal of Pharmaceutics and Biopharmaceutics 136, pages 259-266.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.